Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FAVLL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,353
Award facts
- Contract value 100% obligated
- $69,352.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,352.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Enbrel 50 mg/ml SureClick auto-injector pens with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The place of performance is identified as Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026, which covers a comprehensive portfolio of pharmaceutical products, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide.
Enbrel is a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, and the SureClick auto-injector formulation provides convenient self-administration for patients within military healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of delivery orders for branded and generic pharmaceuticals to military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FAVLL?
SPE2DB25FAVLL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FAVLL worth?
The government has obligated $69,353 on SPE2DB25FAVLL.
Is contract SPE2DB25FAVLL an order under another contract?
Yes. SPE2DB25FAVLL is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVLL competed?
The extent of competition for SPE2DB25FAVLL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award